{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T21:00:01Z","timestamp":1764277201194},"posted":{"date-parts":[[2023,7,26]]},"group-title":"In Review","reference-count":20,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,7,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background<\/jats:bold> Xylazine is an alpha-2 adrenergic receptor agonist that has emerged as a contaminant in the street drug supply of fentanyl. Xylazine use may be suspected in naloxone-resistant overdoses and atypical, chronic wounds in people who inject drugs (PWID). This case is unique because it is the first case to our knowledge describing wound care for a xylazine-induced wound with a confirmatory xylazine test strip (XTS) in the setting of a syringe services program (SSP) and in the state of Florida.<jats:bold>Case Presentation<\/jats:bold> A 43-year-old woman with a past medical history of severe opioid use disorder and stimulant use disorder presented to a student-run clinic at the IDEA Miami SSP for wound care. She had multiple ulcerations diffusely over her bilateral forearms with surrounding erythema and warmth. Seven weeks later, she presented to clinic again for wound care because her wounds had progressed. At this visit, a XTS was used to confirm the presence of xylazine in her urine. Wound care management and harm reduction strategies employed at both visits are discussed below. Wound outcomes are unknown as the patient has not returned to clinic.<jats:bold>Conclusions<\/jats:bold> Many PWID at highest risk for acute and chronic health consequences of xylazine-adulterated fentanyl do not have access to healthcare outside of low barrier clinics and SSPs due to lack of insurance or mistrust of the traditional healthcare system. There is an urgent need for access to XTS for PWID and clinical practice guidelines for the treatment of xylazine-related wounds in outpatient clinics.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3194876\/v1","type":"posted-content","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T18:24:53Z","timestamp":1690395893000},"source":"Crossref","is-referenced-by-count":9,"title":["A Confirmed Case of Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Miami, Florida, USA"],"prefix":"10.21203","author":[{"given":"Peyton V.","family":"Warp","sequence":"first","affiliation":[{"name":"University of Miami Miller School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"Hauschild","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Ciraldo","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Miami Miller School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Serota","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irasema","family":"Cruz","sequence":"additional","affiliation":[{"name":"IDEA Exchange, University of Miami Miller School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"8","key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus","article-title":"Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA","volume":"14","author":"Malayala SV","year":"2022","unstructured":"Malayala SV, Papudesi BN, Bobb R, et al. Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA. Cureus. 2022;14(8). doi:10.7759\/cureus.","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine \u2014 Medical and Public Health Imperatives","volume":"26","author":"Gupta R","year":"2023","unstructured":"Gupta R, Holtgrave DR, Ashburn MA. Xylazine \u2014 Medical and Public Health Imperatives. N Engl J Med. Published online April 26, 2023. doi:10.1056\/NEJMp2303120","journal-title":"N Engl J Med. Published online April"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"109380","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman J","year":"2022","unstructured":"Friedman J, Montero F, Bourgois P, et al. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis. Drug and Alcohol Dependence. 2022;233:109380. doi:10.1016\/j.drugalcdep.2022.109380","journal-title":"Drug and Alcohol Dependence"},{"issue":"37","key":"ref4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.15585\/mmwr.mm7037a5","article-title":"Notes from the Field: Xylazine, a Veterinary Tranquilizer, Identified as an Emerging Novel Substance in Drug Overdose Deaths \u2014 Connecticut, 2019\u20132020","volume":"70","author":"Thangada S","year":"2021","unstructured":"Thangada S, Clinton HA, Ali S, et al. Notes from the Field: Xylazine, a Veterinary Tranquilizer, Identified as an Emerging Novel Substance in Drug Overdose Deaths \u2014 Connecticut, 2019\u20132020. MMWR Morb Mortal Wkly Rep. 2021;70(37):1303\u20131305. doi:10.15585\/mmwr.mm7037a5","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref5","author":"Wallace LA","year":"2023","unstructured":"Wallace L. A Case Of Skin Necrosis Caused By Intravenous Xylazine Abuse. Journal of Hospital Medicine. Accessed May 11, 2023. https:\/\/shmabstracts.org\/abstract\/a-case-of-skin-necrosis-caused-by-intravenous-xylazine-abuse\/"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001198","article-title":"Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut","author":"Dowton A","unstructured":"Dowton A, Doernberg M, Heiman E, et al. Recognition and Treatment of Wounds in Persons Using Xylazine: A Case Report From New Haven, Connecticut. Journal of Addiction Medicine.:10.1097\/ADM.0000000000001198. doi:10.1097\/ADM.0000000000001198","journal-title":"Journal of Addiction Medicine."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.04.009","article-title":"Skin ulcerations caused by xylazine: A less-known entity","volume":"11","author":"Bishnoi A","year":"2023","unstructured":"Bishnoi A, Singh V, Khanna U, Vinay K. Skin ulcerations caused by xylazine: A less-known entity. Journal of the American Academy of Dermatology. Published online April 11, 2023. doi:10.1016\/j.jaad.2023.04.009","journal-title":"Journal of the American Academy of Dermatology. Published online April"},{"issue":"3","key":"ref8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The Emerging of Xylazine as a New Drug of Abuse and its Health Consequences among Drug Users in Puerto Rico","volume":"89","author":"Reyes JC","year":"2012","unstructured":"Reyes JC, Negr\u00f3n JL, Col\u00f3n HM, et al. The Emerging of Xylazine as a New Drug of Abuse and its Health Consequences among Drug Users in Puerto Rico. J Urban Health. 2012;89(3):519\u2013526. doi:10.1007\/s11524-011-9662-6","journal-title":"J Urban Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jdcr.2023.04.010","article-title":"Xylazine-induced acute skin necrosis in two patients who inject fentanyl","volume":"36","author":"Rose L","year":"2023","unstructured":"Rose L, Kirven R, Tyler K, Chung C, Korman AM. Xylazine-induced acute skin necrosis in two patients who inject fentanyl. JAAD Case Rep. 2023;36:113\u2013115. doi:10.1016\/j.jdcr.2023.04.010","journal-title":"JAAD Case Rep"},{"issue":"3","key":"ref10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","article-title":"Drug checking services for people who use drugs: a systematic review","volume":"117","author":"Maghsoudi N","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532\u2013544. doi:10.1111\/add.15734","journal-title":"Addiction"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12954-018-0213-2","article-title":"High willingness to use rapid fentanyl test strips among young adults who use drugs","volume":"15","author":"Krieger MS","year":"2018","unstructured":"Krieger MS, Yedinak JL, Buxton JA, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7. doi:10.1186\/s12954-018-0213-2.","journal-title":"Harm Reduct J"},{"key":"ref12","volume-title":"Evaluation of Xylazine Test Strips (BTNX) for Drug-Checking Purposes","author":"Krotulski AJ","year":"2023","unstructured":"Krotulski AJ; Shinefeld, J; DeBoard, J; Teixeira da Silva, D; Logan, BK (2023) Evaluation of Xylazine Test Strips (BTNX) for Drug-Checking Purposes, Center for Forensic Science Research and Education, United States."},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0379-0738(03)00083-5","article-title":"A reported case involving impaired driving following self-administration of xylazine","volume":"134","author":"Stillwell ME","year":"2003","unstructured":"Stillwell ME. A reported case involving impaired driving following self-administration of xylazine. Forensic Sci Int. 2003;134(1):25\u201328. doi:10.1016\/s0379-0738(03)00083-5","journal-title":"Forensic Sci Int"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.dadr.2022.100074","article-title":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips","volume":"4","author":"Reed MK","year":"2022","unstructured":"Reed MK, Imperato NS, Bowles JM, Salcedo VJ, Guth A, Rising KL. Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips. Drug Alcohol Depend Rep. 2022;4:100074. doi: 10.1016\/j.dadr.2022.100074. PMID: 36846574; PMCID: PMC9949306.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"8","key":"ref15","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","article-title":"Xylazine and Overdoses: Trends, Concerns, and Recommendations","volume":"112","author":"Alexander RS","year":"2022","unstructured":"Alexander RS, Canver BR, Sue KL, Morford KL. Xylazine and Overdoses: Trends, Concerns, and Recommendations. Am J Public Health. 2022;112(8):1212\u20131216. doi:10.2105\/AJPH.2022.306881","journal-title":"Am J Public Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","article-title":"Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States","volume":"63","author":"Peiper NC","year":"2019","unstructured":"Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122\u2013128. doi:10.1016\/j.drugpo.2018.08.007.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1080\/07853890.2021.1993326","article-title":"Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team","volume":"53","author":"Serota DP","year":"2021","unstructured":"Serota DP, Tookes HE, Hervera B, et al. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team. Annals of Medicine. 2021;53(1):1960\u20131968. doi:10.1080\/07853890.2021.1993326","journal-title":"Annals of Medicine"},{"issue":"5","key":"ref18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/00000637-199505000-00007","article-title":"Dry, moist, and wet skin wound repair","volume":"34","author":"Vogt PM","year":"1995","unstructured":"Vogt PM, Andree C, Breuing K, et al. Dry, moist, and wet skin wound repair. Ann Plast Surg. 1995;34(5):493\u2013499; discussion 499\u2013500. doi:10.1097\/00000637-199505000-00007.","journal-title":"Ann Plast Surg"},{"issue":"5","key":"ref19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/1523-1747.ep12476467","article-title":"Comparison of the effects of moist and dry conditions on dermal repair","volume":"91","author":"Dyson M","year":"1988","unstructured":"Dyson M, Young S, Pendle CL, Webster DF, Lang SM. Comparison of the effects of moist and dry conditions on dermal repair. J Invest Dermatol. 1988;91(5):434\u2013439. doi:10.1111\/1523-1747.ep12476467","journal-title":"J Invest Dermatol"},{"key":"ref20","unstructured":"Xylazine-induced wounds"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3194876\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3194876\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T15:38:35Z","timestamp":1710776315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3194876\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3194876\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12954-024-00978-z","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,7,26]]},"subtype":"preprint"}}